Cargando…
Insulin therapy for adult patients with type 2 diabetes mellitus: a position statement of the Korean Diabetes Association, 2017
The Korean Diabetes Association (KDA) has regularly updated its Clinical Practice Guidelines. In 2017, the KDA published a position statement on the use of antihyperglycemic agents for patients with type 2 diabetes mellitus (T2DM). Growing evidence from new multinational clinical trials using novel...
Autores principales: | Lee, Byung-Wan, Kim, Jin Hwa, Ko, Seung-Hyun, Hur, Kyu Yeon, Kim, Nan-Hee, Rhee, Sang Youl, Kim, Hyun Jin, Moon, Min Kyong, Park, Seok-O, Choi, Kyung Mook |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
The Korean Association of Internal Medicine
2017
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5668405/ https://www.ncbi.nlm.nih.gov/pubmed/29057642 http://dx.doi.org/10.3904/kjim.2017.314 |
Ejemplares similares
-
Insulin Therapy for Adult Patients with Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association, 2017
por: Lee, Byung-Wan, et al.
Publicado: (2017) -
Antihyperglycemic agent therapy for adult patients with type 2 diabetes mellitus 2017: a position statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017) -
Antihyperglycemic Agent Therapy for Adult Patients with Type 2 Diabetes Mellitus 2017: A Position Statement of the Korean Diabetes Association
por: Ko, Seung-Hyun, et al.
Publicado: (2017) -
Glucagon-Like Peptide-1 Receptor Agonists for the Treatment of Type 2 Diabetes Mellitus: A Position Statement of the Korean Diabetes Association
por: Kim, Hyun Jin, et al.
Publicado: (2017) -
Monotherapy in patients with type 2 diabetes mellitus
por: Rhee, Sang Youl, et al.
Publicado: (2017)